A week after English band Radiohead opened the shop for its self-released seventh album In Rainbows, Billboard reported yesterday that the band Nine Inch Nails is now celebrating status as a "free agent" as well. Since May, Trent Reznor, the band's front man, has been in a very open dispute about album pricing with Interscope Records, a division of Universal Music Group. Last month, that dispute flared up with Reznor telling fans in Australia and China to steal the album versus paying the high costs to obtain a copy.
According to Billboard, Reznor is very happy "to finally have a direct relationship with the audience as I see fit and appropriate." This is similar to the situation Radiohead has presented to fans, allowing them to set their own price to download In Rainbows. A physical "discbox" sells at a set price around $82, but that physical set comes filled with much more than the standard album. Reznor had questioned the label for charging fans in Australia and China higher prices than in the United States and other regions. The Radiohead price is one set by the band, not the label. The question of high prices still remains though.
Unfortunately, while both of these cases present fans and listeners with improved "relations" it comes from artists that have achieved success and enjoy large and faithful fan bases. What happens to new artists that emerge and find a record industry unwilling to allow them to learn from these informative examples? Will the record industry allow an artist to build a fan base while maintaining the autonomy they wish? Will they be embraced by a record industry open to new ideas, or one that finds new ways to cash in - like taking shares of touring profits, for one?
Last updated: February 09, 2012: 02:15 PM
Hot Stocks
DailyFinance Headlines
- Readers' Tips for Financial Renewal, Part 4: Get the Right Job
- Tax Time for Single Parents Can Be Doubly Aggravating
- BlackBerry Loses to Apple Again
- DVDs Are Dying, and There's Worse News Ahead for Hollywood
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Benzinga Headlines
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
- CVS Profit Up as Walgreen's Customers Defect
TheFlyOnTheWall.com Headlines
- Taleo downgraded to Neutral from Buy at Citigroup
- Occidental Petroleum raises annual dividend 17% to $2.16 per share
- Perficient acquires PointBridge Solutions
- Leapfrog calls more active puts into the expected release of Q4
- Philip Morris says its E.U. sales volume could increase in 2012
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Readers' Tips for Financial Renewal, Part 4: Get the Right Job
- Tax Time for Single Parents Can Be Doubly Aggravating
- BlackBerry Loses to Apple Again
- DVDs Are Dying, and There's Worse News Ahead for Hollywood
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

